Beyond diagnosis: Stage and grade in inflammatory renal disease

Current Diagnostic Pathology

Volumn 10, Issue 1, 2004, Pages 22-35

  Roberts, I S D ^a   Furness, P N ^b   Cook, H T ^c  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b LEICESTER GENERAL HOSPITAL   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Glomerulonephritis; IgA nephropathy; Microscopic vasculitis; Renal biopsy; Systemic lupus erythematosus

Indexed keywords

CLINICAL PRACTICE; CONFERENCE PAPER; CYTODIAGNOSIS; DIAGNOSTIC APPROACH ROUTE; DISEASE ACTIVITY; DISEASE CLASSIFICATION; GLOMERULONEPHRITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; MICROSCOPIC VASCULITIS; MOLECULAR DYNAMICS; MORPHOMETRICS; STAGING; VASCULITIS;

EID: 1642471826     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cdip.2003.09.002     Document Type: Conference Paper

References (58)

1. Pollak VE, Pirani CL, Schwartz FD. The natural history of the renal manifestations of systemic lupus erythematosus. J Lab Clin Med 1964;63:537-50.
2. Baldwin DS, Lowenstein J, Rothfield NF, Gallo G, McCluskey RT. The clinical course of proliferative and membranous forms of lupus nephritis. Ann Intern Med 1970;73:929-42.
3. Appel GB, Silva FG, Pirani CL, Meltzer JI, Estes D. Renal involvement in systemic lupus erythematosus (SLE): a study of 56 patients emphasizing histologic classification. Medicine 1978;75:371-410.
4. Appet GB, Cohen DJ, Pirani CL, Meltzer JI, Estes D. Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organisation. Am J Med 1987;83:877-85.
5. Churg J and Sobin LH. Renal disease: classification and atlas of glomerular disease. Tokyo: Igaku-Shoin; 1982.
6. Churg, J, Bernstein J, and Glassock RJ. Renal disease: classification and atlas of glomerular diseases. New York: Igaku-Shoin; 1995.
7. Najafi CC, Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J. Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephrits. Kidney Int 2001;59:2156-63.
8. Pirani CL, Pollak VE, Schwartz FD. The reproducibility of semiquantitative analysis of renal histology. Nephron 1964;1:230-9.
9. Austin HA III, Muenz LR, Joyce KM, Antonovych TT, Balow JE. Diffuse proliferative glomerulonephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 1984;25:689-95.
10. Austin HA III, Muenz LR, Joyce KM, et at. Prognostic factors in lupus nephritis. Contribution of renal histological data. Am J Med 1983;75:382-91.
11. Schwartz MM, Bernstein J, Hill G, Holley K, Phillips EA. Predictive value of renal pathology in diffuse proliferative lupus glomerulonephritis. Kidney Int 1989;36:891-6.
12. Schwartz MM, Lan S-P, Bernstein J, Hill GS, Holley K, Lewis EJ. Role of pathology indices in the management of sever lupus glomerulonephritis. Kidney Int 1992;42:743-8.
13. Schwartz MM, Lan S-P, Bernstein J, Hill GS, Holley K, Lewis EJ. Irreproducibility of the activity and chronicity indices limits their utility in the management of lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis 1993;21:374-7.
14. Wernick RM, Smith DL, Houghton DC, et al. Reliability of histologic scoring for lupus nephritis: a community-based evaluation. Ann Intern Med 1993;119:805-11.
15. Andrassy K, Erb A, Koderisch J, Waldherr R, Ritz E. Wegener's granulomatosis with renal involvement: patient survival and correlations between initial renal function, renal histology, therapy and outcome. Clin Nephrol 1991;35:139-47.
16. Serra A, Cameron JS, Turner DR, et al. Vasculitis affecting the kidney: presentation, histopathology and long-term outcome. Q J Med 1984;53:181-207.
17. Savage COS, Winearls CG, Evans DJ, Rees AJ, Lockwood CM. Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 1985;56:467-83.
18. Furlong TJ, Ibels LS, Eckstein RP. The clinical spectrum of necrotizing glomerulonephritis. Medicine 1987;66:192-201.
19. Gans ROB, Kuizinga MC, Goldschmeding R, et al. Clinical features and outcome in patients with glomerulonephritis and antineutrophil cytoplasmic antibodies. Nephron 1993;64:182-8.
20. Bajema IM, Hagen EC, Hermans J, et al. Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int 1999;56:1751-8.
21. Hogan SL, Nachman PH, Wilkman AS, Jenette JC, Falk RJ. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996;7:23-32.
22. Hauer HA, Bajema IM, van Houwelingen HC, et al. Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients. Kidney Int 2002;62:1732-42.
23. Ballardie FW, Roberts ISD. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy. J Am Soc Nephrol 2002;13:142-8.
24. To KF, Choi PC, Szeto CC. Outcome of IgA nephropathy in adults graded by chronic histological lesions. Am J Kidney Dis 2000;35:392-400.
25. Mera J, Uchida S, Nagase M. Clinicopathologic study on prognostic markers in IgA nephropathy. Nephron 2000;84:148-57.
26. Daniel L, Saingra Y, Giorgi R, Bouvier C, Pellissier JF, Berland Y. Tubular lesions determine prognosis of IgA nephropathy. Am J Kidney Dis 2000;35:13-20.
27. Vleming LJ, de Fijter JW, Westendorp RG, Daha MR, Bruijn JA, van Es LA. Histomorphometric correlates of renal failure in IgA nephropathy. Clin Nephrol 1998;49:337-44.
28. Freese P, Norden G, Nyberg G. Morphologic high-risk factors in IgA nephropathy. Nephron 1998;79:420-5.
29. Hogg RJ, Silva FG, Wyatt RJ, Reisch JS, Argyle JC, Savino DA. Prognostic indicators in children with IgA nephropathy-report of the Southwest Pediatric Nephrology Study Group. Pediatr Nephrol 1994;8:15-20.
30. Katafuchi R, Oh Y, Hori K, et al. An important role of glomerular segmental lesions on progression of IgA nephropathy: a multivariate analysis. Clin Nephrol 1994;41:191-8.
31. Ibels LS, Gyory AZ. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine (Baltimore) 1994;73:79-102.
32. Okada H, Suzuki H, Konishi K, Sakaguchi H, Saruta T. Histological alterations in renal specimens as indicators of prognosis of IgA nephropathy. Clin Nephrol 1992;37:235-8.
33. Bogenschutz O, Bohle A, Batz C, et al. IgA nephritis: on the importance of morphological and clinical parameters in the long-term prognosis of 239 patients. Am J Nephrol 1990;10:137-47.
34. Rekola S, Bergstrand A, Bucht H. IgA nephropathy: a retrospective evaluation of prognostic indices in 176 patients. Scand J Urol Nephrol 1989;23:37-50.
35. D'Amico G, Minetti L, Ponticelli C, et al. Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med 1986;59:363-78.
36. Boyce NW, Holdsworth SR, Thomson NM, Atkins RC. Clinicopathological associations in mesangial IgA nephropathy. Am J Nephrol 1986;6:246-52.
37. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999;55:713-23.
38. Goumenos DS, Brown CB, Shortland J, El Nahas AM. Myofibroblasts, predictors of progression of mesangial IgA nephropathy. Nephrol Dial Transplant 1994;9:1418-25.
39. Roberts ISD, Burrows C, Shanks JH, Venning M, McWilliam LJ. Interstitial myofibroblasts: predictors of progression in membranous nephropathy. J Clin Pathol 1997;50:123-7.
40. Roberts ISD, Brenchley PEC. Mast cells: the forgotten cells of renal fibrosis. J Clin Pathol 2000;53:858-62.
41. Kurusu A, Suzuki Y, Horikoshi S, Shirato I, Tomino Y. Relationship between mast cells in the tubulointerstitium and prognosis of patients with IgA nephropathy. Nephron 2001;89:391-7.
42. Nieuwhof C, Kruytzer M, Frederiks P, van Breda Vriesman PJ. Chronicity index and mesangial IgG deposition are risk factors for hypertension and renal failure in early IgA nephropathy. Am J Kidney Dis 1998;31:962-70.
43. Tomiyoshi Y, Sakemi T, Ikeda Y, Ohtsuka Y, Nakamura M, Fujisaki T. Cellular crescents and segmental glomerular necrosis in IgA nephropathy are indicative of the beneficial effects of corticosteroid therapy. Intern Med 2001;40:862-6.
44. Radford Jr MG, Donadio Jr JV, Bergstrath EJ, Grande JP. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 1997;8:199-207.
45. Alamartine E, Sabatier JC, Guerin C, Berliet JM, Berthoux F. Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses. Am J Kidney Dis 1991;18:12-9.
46. Katafuchi R, Kiyoshi Y, Oh Y, et al. Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation. Clin Nephrol 1998;49:1-8.
47. Meadow SR, Glasgow EF, White RHR, Moncrieff MW, Cameron JS, Ogg CS. Schontein-Henoch nephritis. Q J Med 1972;163:241-58.
48. Lee S-MK, Rao VM, Franklin WA, et al. IgA nephropathy: morphologic predictors of progressive renal disease. Hum Pathol 1982;13:314-22.
49. Haas M. Histological subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis 1997;29:829-42.
50. Emancipator SN. IgA nephropathy, Henoch-Schontein syndrome. In: Jennette JC, Olson JL, Schwartz MM, Silva FG (editors). Heptinstall's Pathology of the Kidney, 5th Edn. Philadelphia: Lippincott-Raven; 1998: 482.
51. Yoshimura M, Kida H, Abe T, Takeda S, Katagiri M, Hattori N. Significance of IgA deposits on the glomerular capillary walls in IgA nephropathy. Am J Kidney Dis 1987;9:404-9.
52. Andreoti SP, Yum MN, Bergstein JM. IgA nephropathy in children: significance of glomerular basement membrane deposition of Iga. Am J Nephrol 1986;6:28-33.
53. Furness PN, Taub N. International variation in the interpretation of renal transplant biopsies: report of the CERTPAP project. Kidney Int 2001;60:1998-2012.
54. Howie AJ, Ferreira MA, Adu D. Prognostic value of simple measurement of chronic damage in renal biopsy specimens. Nephrol Dial Transplant 2001;16:1163-9.
55. McCulloch TA, Harper SJ, Donnelly PK, et al. Influence of nifedipine on interstitial fibrosis in renal transplant allografts treated with cyctosporin A. J Clin Pathol 1994;47:839-42.
56. Grimm PC, Nickerson P, Gough J, et al. Computerized image analysis of sirius red-stained renal allograft biopsies as a surrogate marker to predict tong-term allograft function. J Am Soc Nephrol 2003;14:1662-8.
57. Furness PN, Rogers-Wheatley L, Harris KP. Semiautomatic quantitation of macrophages in human renal biopsy specimens in proteinuric states. J Clin Pathol 1997;50:118-22.
58. Robertson H, Morley AR, Talbot D, Callanan K, Kirby JA. Renal allograft rejection: beta-chemokine involvement in the development of tubulitis. Transplantation 2000;69:684-7.